Revolution Medicines RVMD
NASDAQ RVMD
$208.71 -2.15 (-1.02%)
As of: Sep 4, 2026 · 3:16 PM EDT

Revolution Medicines (RVMD) EBT Margin (QoQ) (2019 - 2023)

Analysis

Revolution Medicines (RVMD) EBT Margin (QoQ) (2019 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -159,967.00
Mar 31, 2023 -60,148.00
Dec 31, 2022 182,446.00
Sep 30, 2022 -152,227.00
Jun 30, 2022 8,913.00
Mar 31, 2022 -20,389.00
Dec 31, 2021 425,153.00
Sep 30, 2021 -429,906.00
Jun 30, 2021 -14,235.00
Mar 31, 2021 1,977.00
Dec 31, 2020 -17,172.00
Sep 30, 2020 5,705.00
Jun 30, 2020 -9,715.00
Mar 31, 2020 -1,798.00
Dec 31, 2019 -5,443.00
Sep 30, 2019 -2,010.00
Jun 30, 2019 -545.00